Citation: | WU Xian, WANG Hai-bo, LOU Chao-sheng, ZHANG Yin, YE Le-chi. Effect of Yiwei Fuzheng Decoction on Qi deficiency and blood stasis type precancerous lesion and its related mechanism[J]. Chinese Journal of General Practice, 2021, 19(6): 1017-1021. doi: 10.16766/j.cnki.issn.1674-4152.001974 |
[1] |
MALIK T H, SAYAHAN M Y, AL AHMED H A, et al. Gastric intestinal metaplasia: an intermediate precancerous lesion in the cascade of gastric carcinogenesis[J]. J Coll Physicians Surg Pak, 2017, 27(3): 166-172. http://europepmc.org/abstract/MED/28406776
|
[2] |
杨阔, 刘华一, 王秀娟, 等. 胃转安方治疗胃癌前病变患者临床观察及胃蛋白酶原(PG)的影响[J]. 中华中医药学刊, 2016, 34(10): 2464-2467. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201610044.htm
|
[3] |
TAPIA O, RIQUELME I, LEAL P, et al. The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance[J]. Virchows Archiv, 2014, 465(1): 25-33. doi: 10.1007/s00428-014-1588-4
|
[4] |
INAGAKI-OHARA K, OKAMOTO S, TAKAGI K, et al. Leptin receptor signaling is required for high-fat diet-induced atrophic gastritis in mice[J]. Nutr Metab, 2016, 13(1): 7. doi: 10.1186/s12986-016-0066-1
|
[5] |
房静远, 杜奕奇, 刘文忠, 等. 中国慢性胃炎共识意见精简版(2017年, 上海)[J]. 上海医学, 2017, 40(12): 705-708. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYX201712001.htm
|
[6] |
张万岱, 李军祥, 陈治水, 等. 慢性胃炎中西医结合诊疗共识意见(2011年天津)[J]. 中国中西医结合杂志, 2012, 32(6): 738-743. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201206009.htm
|
[7] |
郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京: 中国医药科技出版社, 2002: 124-129.
|
[8] |
袁星星, 王炳予, 杨磊, 等. 丹芪祛瘀止痛颗粒对气虚血瘀型胃癌前病变患者胃黏膜组织TRAF1、4-1BB、Bcl-xL表达的影响[J]. 中医杂志, 2017, 58(13): 1130-1134. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201713013.htm
|
[9] |
中华医学会消化病学分会. 全国慢性胃炎研讨会共识意见[J]. 中华消化杂志, 2000, 20(3): 199-201. doi: 10.3760/j.issn:0254-1432.2000.03.015
|
[10] |
陈万青, 郑荣寿, 张思维, 等. 2013年中国恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2017, 26(1): 1-7. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201701001.htm
|
[11] |
周亮, 赵瑶, 朱伟, 等. 胃癌前病变转归影响因素回顾性队列研究[J]. 中国公共卫生, 2013, 29(8): 1154-1157. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGGW201308020.htm
|
[12] |
MING S C, BAJTAI A, CORREA P, et al. Gastric dysplasia. Significance and pathologic criteria[J]. Cancer, 1984, 54(9): 1794-1801. doi: 10.1002/1097-0142(19841101)54:9<1794::AID-CNCR2820540907>3.0.CO;2-W
|
[13] |
张德英, 侯卓成, 李卫强. 中医药治疗胃癌前病变研究进展[J]. 辽宁中医杂志, 2016, 43(1): 207-210. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201601086.htm
|
[14] |
李珍一, 杨关林, 闫承慧, 等. 黄芪多糖应用的相关研究进展[J]. 辽宁中医杂志, 2016, 43(7): 1553-1555. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201607068.htm
|
[15] |
蔡翔, 陈培红, 饶玉凤. 仙鹤草的临床新用[J]. 中国中医基础医学杂志, 2016, 22(8): 1109-1110. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC201608037.htm
|
[16] |
张永宏, 张太坤, 顾宗明, 等. 消萎汤辨证加味治疗胃癌前病变的临床疗效[J]. 辽宁中医杂志, 2016, 43(9): 1912-1915. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201609043.htm
|
[17] |
韦维, 林寿宁, 汪波, 等. 安胃汤对慢性萎缩性胃炎大鼠PI3K/Akt信号传导通路的影响[J]. 辽宁中医杂志, 2018, 45(5): 1088-1091, 1122. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201805060.htm
|
[18] |
袁美杰, 邵晨曦, 杜玉青, 等. 基于蛋白激酶B/雷帕霉素靶蛋白通路观察化浊解毒方对胃癌前病变大鼠肿瘤血管新生机制的影响[J]. 河北中医, 2017, 39(2): 260-263, 292. https://www.cnki.com.cn/Article/CJFDTOTAL-HBZY201702025.htm
|
[19] |
YING J, XU Q, LIU B, et al. The expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosis[J]. Onco Targets Ther, 2015, 8: 2427-2433. http://europepmc.org/articles/PMC4562727/pdf/ott-8-2427.pdf
|
[20] |
RIQUELME I, TAPIA O, ESPINOZA J A, et al. The gene expression status of the PI3K/AKT/mTOR pathway in Gastric Cancer Tissues and cell lines[J]. Pathol Oncol Res, 2016, 22(4): 797-805. http://europepmc.org/abstract/med/27156070
|
[21] |
赵海梅, 黄敏芳, 刘端勇, 等. 黄芪多糖对急性溃疡性结肠炎大鼠结肠黏膜PI3K/Akt信号的调控作用[J]. 中成药, 2015, 37(9): 2029-2031. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA201509035.htm
|
[22] |
宋杰, 李静, 黄铁柱, 等. 黄芪多糖对肝癌细胞生长增殖凋亡及AMPK-mTOR信号通路的影响[J]. 中国医师杂志, 2015, 17(5): 667-670, 674.
|